- Home
- IFS vs MIRM Comparison
IFS vs MIRM Comparison
Compare IFS & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IFS | MIRM |
|---|---|---|
| Founded | 1897 | 2018 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.7B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | IFS | MIRM |
|---|---|---|
| Price | $50.26 | $99.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | $48.00 | ★ $119.85 |
| AVG Volume (30 Days) | 225.6K | ★ 1.0M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ 74.59 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,138,000.00 |
| Revenue This Year | N/A | $26.22 |
| Revenue Next Year | $7.38 | $22.04 |
| P/E Ratio | $9.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.20 | $43.40 |
| 52 Week High | $53.00 | $114.99 |
Technical Indicators
Market Signals| Indicator | IFS | MIRM |
|---|---|---|
| Relative Strength Index (RSI) | 64.10 | 48.64 |
| Support Level | $42.73 | $97.49 |
| Resistance Level | $52.25 | $107.51 |
| Average True Range (ATR) | 1.64 | 6.00 |
| MACD | 0.75 | -0.99 |
| Stochastic Oscillator | 92.13 | 24.05 |
Price Performance
Historical ComparisonAbout IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.